Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children With Peanut Allergy
Author(s) -
David M. Fleischer,
Matthew Greenhawt,
Gordon L. Sussman,
Philippe Bégin,
AnowakWęgrzyn,
Daniel Petroni,
Kirsten Beyer,
Terri BrownWhitehorn,
Jacques Hébert,
Jonathan O’B Hourihane,
Dianne E. Campbell,
Stephanie A. Leonard,
R. Sharon Chinthrajah,
Jacqueline A. Pongracic,
Stacie M. Jones,
Lars Lange,
Hey Chong,
Todd D. Green,
Robert A. Wood,
Amarjit Cheema,
Susan L. Prescott,
Peter Smith,
William H. Yang,
Edmond S. Chan,
Aideen Byrne,
Amal Assa’ad,
J. Andrew Bird,
Edwin Kim,
Lynda C. Schneider,
Carla M. Davis,
Bruce J. Lanser,
Romain Lambert,
Wayne G. Shreffler
Publication year - 2019
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2019.1113
Subject(s) - medicine , peanut allergy , placebo , adverse effect , allergy , randomized controlled trial , ingestion , oral food challenge , food allergy , immunology , alternative medicine , pathology
There are currently no approved treatments for peanut allergy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom